Compare BTCS & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BTCS | BHST |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | United States | Canada |
| Employees | N/A | 89 |
| Industry | Finance: Consumer Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.8M | 61.2M |
| IPO Year | 2008 | N/A |
| Metric | BTCS | BHST |
|---|---|---|
| Price | $0.99 | $2.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $5.00 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 605.8K | 55.1K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,491,584.00 | N/A |
| Revenue This Year | $21.23 | $146.27 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 304.85 | N/A |
| 52 Week Low | $0.96 | $1.82 |
| 52 Week High | $6.15 | $12.80 |
| Indicator | BTCS | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 45.13 | 30.21 |
| Support Level | $0.97 | $1.82 |
| Resistance Level | $1.09 | $3.47 |
| Average True Range (ATR) | 0.06 | 0.25 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 60.66 | 24.79 |
BTCS Inc. ("BTCS" or the "Company"), short for Blockchain Technology Consensus Solutions, is a U.S.-based Ethereum-first blockchain technology company committed to driving scalable revenue and ETH accumulation through its hallmark strategy, the DeFi/TradFi Accretion Flywheel, an integrated approach to capital formation and blockchain infrastructure. By combining decentralized finance ("DeFi") and traditional finance ("TradFi") mechanisms with its blockchain infrastructure operations, comprising NodeOps (staking) and Builder+ (block building), BTCS offers one of the most sophisticated opportunities for leveraged ETH exposure, driven by scalable revenue generation and a yield-focused ETH accumulation strategy. Discover how BTCS offers operational and financial leveraged exposure to Ethereum through the public markets at www.btcs.com.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.